Abstract:HistopathologyVolume 52, Issue 2 p. 247-250 Mutant L Homologue 1 (MLH1): a possible new immunohistochemical marker for prostatic cancer S-T Chuang, S-T Chuang Departments of PathologySearch for more papers by this authorB Adley, B Adley Departments of PathologySearch for more papers by this authorM Han, M Han Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this authorF Lin, F Lin Department of Pathology, Geisinger Medical Center, Danville, PA, USASearch for more papers by this authorX J Yang, X J Yang Departments of Pathology Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this authorW J Catalona, W J Catalona Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this author S-T Chuang, S-T Chuang Departments of PathologySearch for more papers by this authorB Adley, B Adley Departments of PathologySearch for more papers by this authorM Han, M Han Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this authorF Lin, F Lin Department of Pathology, Geisinger Medical Center, Danville, PA, USASearch for more papers by this authorX J Yang, X J Yang Departments of Pathology Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this authorW J Catalona, W J Catalona Urology, Northwestern University Feinberg School of Medicine, Chicago, ILSearch for more papers by this author First published: 13 November 2007 https://doi.org/10.1111/j.1365-2559.2007.02879.xRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Burmester JK, Suarez BK, Lin JH et al. Analysis of candidate genes for prostate cancer. Hum. Hered. 2004; 57; 172–178. 10.1159/000081443 CASPubMedWeb of Science®Google Scholar 2 Strand M, Prolla TA, Liskay RM, Petes TD. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993; 365; 274–276. 10.1038/365274a0 CASPubMedWeb of Science®Google Scholar 3 Cunningham JM, Shan A, Wick MJ et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res. 1996; 56; 4475–4482. CASPubMedWeb of Science®Google Scholar 4 Egawa S, Uchida T, Suyama K et al. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables. Cancer Res. 1995; 55; 2418–2421. CASPubMedWeb of Science®Google Scholar 5 Gao X, Wu N, Grignon D et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 1994; 9; 2999–3003. CASPubMedWeb of Science®Google Scholar 6 Yeh CC, Lee C, Dahiya R. DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem. Biophys. Res. Commun. 2001; 285; 409–413. 10.1006/bbrc.2001.5187 CASPubMedWeb of Science®Google Scholar 7 Chen Y, Wang J, Fraig MM et al. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int. J. Oncol. 2003; 22; 1033–1043. CASPubMedWeb of Science®Google Scholar 8 Chen Y, Wang J, Fraig MM et al. Defects of DNA mismatch repair in human prostate cancer. Cancer Res. 2001; 61; 4112–4121. CASPubMedWeb of Science®Google Scholar 9 Caldes T, Godino J, Sanchez A et al. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep. 2004; 12; 621–629. CASPubMedWeb of Science®Google Scholar Volume52, Issue2January 2008Pages 247-250 ReferencesRelatedInformation

Complex MSH2 and MSH6 Mutations in Hypermutated Microsatellite Unstable Advanced Prostate Cancer

Mutant L Homologue 1 (MLH1): a Possible New Immunohistochemical Marker for Prostatic Cancer

Clinicopathological and Molecular Analysis of Microsatellite Instability in Prostate Cancer: a Multi-Institutional Study in China.

The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer

High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry

An integrative pan-cancer analysis reveals the oncogenic role of mutS homolog 6 (MSH6) in human tumors

A Pan-Cancer Analysis on the Systematic Correlation of MutS Homolog 2 (MSH2) to a Malignant Tumor

Genomic Profiling and Mutation Burden of Chinese Prostate Patients with Microsatellite Instability.

Prostate Ductal Adenocarcinoma with MLH1 Copy Number Loss, Microsatellite Instability High and BRCA2 Mutation

Mismatch Repair Gene Germline Mutations in Patients with Prostate Cancer.

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

Clinical Retrospective Analysis: Higher Rates of Gene Mutations in the Microsatellite Stable (MSS) Population of Colorectal Cancer

Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical Outcome.

Microsatellite instability in mismatch repair proficient colorectal cancer: clinical features and underlying molecular mechanisms

Expression of MSH6 and PMS2 protein in prostate cancer and its correlation with occurrence and development

Germline Mutation in Multiple Primary Malignancies Associated with Prostate Cancer.

Association of MSH6 mutation with glioma susceptibility, drug resistance and progression.

Mutations in Mismatch Repair Genes and Microsatellite Instability Status in Pancreatic Cancer

High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6

Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer

Lower degree of microsatellite instability in colorectal carcinomas from MSH6-associated Lynch syndrome patients